FDA Inspection 553004 — Stepan Company
The FDA completed an inspection of Stepan Company on Dec 18, 2008 in Maywood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 18, 2008
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Maywood, NJ (United States)